blue cross blue shield plans reverse course on glp-1 coverage Why we are changing of drugs for weight loss A handful of nonprofit Blue

Always refer to the individual SmPC for specific guidance

[DOI] [PubMed] [Google Scholar] 2.Roth G.A., Mensah G.A., Johnson C.O., Addolorato G., Ammirati E., Baddour L.M., Barengo N.C., Beaton A.Z., Benjamin E.J., Benziger C.P., et al

Approval for Diabetes and Weight Management Over the past decade, three GLP-1/GIP receptor agonists liraglutide, semaglutide, and tirzepatide initially approved by the FDA for adults with type 2 diabetes, have also gained FDA approval for chronic weight management in people without diabetes, provided they meet specific criteria: a BMI of 30, or 27 with at least one weight-related condition such as hypertension, dyslipidemia, or type 2 diabetes

And neither do you

It's absolutely like having a second chance at life, one that you never thought that you could have

That single fact shapes everything else about GLP-1 coverage on Cigna plans